Senior insider sale
PRESIDENT AND CEO at HALOZYME THERAPEUTICS, INC. — senior position signals high conviction
$16.48M
226.57K shares
What this filing means
TORLEY HELEN plans to sell 226.57K shares of HALOZYME THERAPEUTICS, INC. valued at approximately $16.48M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/3/2026ACC: 0001968582-26-000077
DirectorOfficer· PRESIDENT AND CEO
Since Mar 2026
226.57K
Shares to sell
$16.48M
Approx. market value
150K
Acquired (3 months)
1
Planned
4 completed
Securities Acquired — Last 3 Months1
Stock Option Exercise
Cash
2/3/2026
150KTotal acquired150K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/3/2026 | Stock Option Exercise Cash | 150K | — |
| Total | 150K | ||
Planned & Completed Dispositions5
Completed
—Completed
Units to sell
16.57K
Market value
$1.14M
12/1/2025
—Completed
Units to sell
20K
Market value
$1.41M
11/12/2025
—Completed
Units to sell
20K
Market value
$1.38M
11/11/2025
—Completed
Units to sell
20K
Market value
$1.37M
11/10/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
150K
Market value
$11.17M
2/3/2026
Total
Units
226.57K
Value
$16.48M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
12/1/2025 | 16.57K | $1.14M | — | Completed |
11/12/2025 | 20K | $1.41M | — | Completed |
11/11/2025 | 20K | $1.38M | — | Completed |
11/10/2025 | 20K | $1.37M | — | Completed |
| Planned — Approximate Date | ||||
2/3/2026 | 150K | $11.17M | NASDAQ | Planned |
| Total | 226.57K | $16.48M | ||